The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor

Nerve growth factor is a therapeutic candidate for Alzheimer’s disease. Due to its pain-inducing activity, in current clinical trials nerve growth factor is delivered locally into the brain by neurosurgery, but data on the efficacy of local nerve growth factor delivery in decreasing amyloid-β deposi...

Full description

Saved in:
Bibliographic Details
Published in:Brain
Main Authors: Capsoni, Simona, Malerba, Francesca, Carucci, Nicola Maria, Rizzi, Caterina, Criscuolo, Chiara, Origlia, Nicola, Calvello, Mariantonietta, Viegi, Alessandro, Meli, Giovanni, Cattaneo, Antonino
Format: Artigo
Language:Inglês
Published: Oxford University Press 2017
Subjects:
Original Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5379860/
https://ncbi.nlm.nih.gov/pubmed/28031222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/brain/aww271
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items